Login / Signup

Response to MEK Inhibitor Therapy in MAP2K1 ( MEK1 ) K57N Non-Small-Cell Lung Cancer and Genomic Landscape of MAP2K1 Mutations in Non-Small-Cell Lung Cancer.

Michael L ChengJessica K LeeRachit KumarHarry KleinKira RaskinaAlexa B SchrockKesi S MichaelTali MazorEthan CeramiGeoffrey R OxnardDavid R LiuHimisha BeltranLynette M ShollMizuki NishinoPasi A Janne
Published in: JCO precision oncology (2022)
Keyphrases
  • pi k akt
  • high density
  • single cell
  • signaling pathway
  • gene expression